Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Testing efficacy or toxicity of a compound or composition
Reexamination Certificate
2006-06-06
2006-06-06
Swartz, Rodney P (Department: 1645)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Testing efficacy or toxicity of a compound or composition
C424S009100, C424S093100, C424S093400, C424S184100, C424S234100, C424S264100, C435S243000, C435S870000
Reexamination Certificate
active
07056492
ABSTRACT:
The present invention relates to methods for treating or preventing a disease or disorder in an animal caused by infection byMycoplasma bovis(M. bovis) by administering to the animal an effective amount of aMycoplasma hyopneumoniae(M. hyo) vaccine. TheM. hyovaccine can be a whole or partial cell inactivated or modified live preparation, a subunit vaccine, or a nucleic acid or DNA vaccine. TheM. hyovaccine administered in accordance with the present invention can be synthesized or recombinantly produced.
REFERENCES:
patent: 5565205 (1996-10-01), Petersen et al.
patent: 5788962 (1998-08-01), McIntosh et al.
patent: WO 91 15593 (1991-10-01), None
Tarasiuk, K., et al., Efficacy of Immunoprophylaxis in the Control of Mycoplasmal Pneumonia of Swine, Medycyna Weterynaryjna, vol. 48, No. 9, 1992, pp. 402-405.
Goudie Alexander C.
Keich Robin Lee
Peters Andrew Raymond
Gumbleton Timothy J.
Pfizer Inc.
Swartz Rodney P
Wootton Thomas A.
LandOfFree
Mycoplasma hyopneumoniae vaccine and methods for reducing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mycoplasma hyopneumoniae vaccine and methods for reducing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mycoplasma hyopneumoniae vaccine and methods for reducing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3617948